Quetiapine
Product Images NDC 53002-1516

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Quetiapine (NDC 53002-1516). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl530021516)

Quetiapine 100 mg IR Tablets packaging label from RPK Pharmaceuticals, Inc., displaying information for 30 count bottles. The label includes the proprietary name, active ingredient Quetiapine Fumarate, dosage strength of 100 mg, tablet count, directions to take as directed, and typical prescription labeling elements such as lot number, expiration date, and barcode.*

FDA Label Image

Figure 1 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 7) (Quetiapine Fig1)

A line graph showing the proportion of patients with relapse (%) over time in weeks. Two lines represent different treatment groups: QTP + Li/VAL and PDL + Li/VAL. The x-axis marks time from 0 to 100 weeks, and the y-axis marks relapse proportion from 0% to 100%. The graph compares relapse rates between the two groups across the study period.*

FDA Label Image

Figure 2 Kaplan-meier Curves Of Time To Recurrence Of A Mood Event (study 8) (Quetiapine Fig2)

A line graph depicting the proportion of patients with relapse (%) over time (weeks) up to 100 weeks. The graph compares two groups: QTP+ LIVAL (dashed line) and PLA+ LIVAL (solid line), showing relapse rates increasing over time for both groups with PLA+ LIVAL having a higher relapse proportion.*

FDA Label Image

Chemstructure (Quetiapine Str)

Chemical structure of quetiapine, showing its molecular framework including a dibenzothiazepine moiety, piperazine ring, and ethanol substituent, presented as a quetiapine salt with an additional counter ion structure.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.